Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN | 16MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166595 |
| APO-CANDESARTAN | 8MG | TABLET | Resolved | 2017-08-08 | 2020-02-25 | 18520 |
| APO-CANDESARTAN | 16MG | TABLET | Resolved | 2017-03-11 | 2017-06-27 | 639 |
| APO-CANDESARTAN | 16MG | TABLET | Resolved | 2021-05-14 | 2021-07-30 | 139406 |
| APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2021-10-22 | 2021-10-22 | 147815 |
| APO-CANDESARTAN | 16MG | TABLET | Resolved | 2020-06-24 | 2020-09-21 | 118763 |
| APO-CANDESARTAN | 8MG | TABLET | Resolved | 2020-04-13 | 2020-10-19 | 111895 |
| APO-CANDESARTAN | 16MG | TABLET | Resolved | 2018-01-03 | 2020-02-25 | 34838 |
| APO-CANDESARTAN | 32MG | TABLET | Resolved | 2017-03-20 | 2020-02-25 | 3516 |
| APO-CANDESARTAN | 4MG | TABLET | Resolved | 2017-08-08 | 2020-02-25 | 18517 |
| APO-CANDESARTAN TABLETS | 4MG | TABLET | Actual shortage | 2025-08-21 | 2025-08-21 | 265823 |
| APO-CANDESARTAN TABLETS | 4MG | TABLET | Resolved | 2024-10-04 | 2024-12-06 | 239358 |
| APO-CANDESARTAN TABLETS | 4MG | TABLET | Resolved | 2024-10-04 | 2025-01-17 | 239355 |
| APO-CANDESARTAN TABLETS | 16MG | TABLET | Resolved | 2025-03-20 | 2025-04-11 | 253078 |
| APO-CANDESARTAN TABLETS | 16MG | TABLET | Resolved | 2024-09-20 | 2025-03-07 | 238233 |
| APO-CANDESARTAN TABLETS | 16MG | TABLET | Resolved | 2024-12-12 | 2025-03-07 | 245502 |
| APO-CANDESARTAN TABLETS | 8MG | TABLET | Resolved | 2025-01-30 | 2025-03-14 | 249077 |
| APO-CANDESARTAN TABLETS | 4MG | TABLET | Actual shortage | 2025-10-16 | 2025-10-16 | 269760 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-11-07 | 2018-02-26 | 28539 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-09-07 | 2018-02-26 | 21199 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |